Skip to main content
Elsevier

Gold Nanoparticle Therapeutics in Alzheimer's Disease

Revolutionizing Diagnosis and Treatment

  • 1st Edition - December 1, 2026
  • Latest edition
  • Editors: Arun Kumar Singh, Mahesh Narayan, Ashutosh Pareek
  • Language: English

Gold Nanoparticle Therapeutics in Alzheimer's Disease: Revolutionizing Diagnosis and Treatment is an essential resource that delves into the groundbreaking use of nanote… Read more

Data Mining & ML

Unlock the cutting edge

Up to 20% on trusted resources. Build expertise with data mining, ML methods.

Explore now

Description

Gold Nanoparticle Therapeutics in Alzheimer's Disease: Revolutionizing Diagnosis and Treatment is an essential resource that delves into the groundbreaking use of nanotechnology in the fight against one of the most challenging neurodegenerative disorders. This volume offers an in-depth exploration on how gold nanoparticles can be used to enhance the diagnosis, treatment, and overall understanding of Alzheimer's disease. By examining the molecular mechanisms that enable nanoparticles to cross the blood-brain barrier, the book highlights their role in inhibiting amyloid fibrils and their potential as precise diagnostic tools.

Covering a wide range of topics, this comprehensive guide serves as an invaluable reference for researchers, clinicians, and industry professionals at the forefront of Alzheimer's research and nanomedicine.

Key features

  • Provides practical examples and case studies, illustrating how these mechanisms can be utilized in real-world scenarios
  • Describes the specific mechanisms through which nanocarrier-based delivery systems can enhance drug effectiveness
  • Includes an extensive review on how gold nanoparticles have been used in various therapeutic contexts

Readership

Researchers, clinicians, and graduate students in the fields of Alzheimer's research and nanotechnology

Table of contents

1. Introduction to Alzheimer’s Disease: Current Challenges and Opportunities

2. Fundamentals of Gold Nanoparticles: Properties, Synthesis, and Functionalization

3. Pathophysiological Mechanisms of Alzheimer’s Disease and Gold Nanoparticles Intervention

4. Diagnostic Applications of Gold Nanoparticles in Alzheimer’s Disease

5. Gold Nanoparticles for Drug Delivery in Alzheimer’s Disease

6. Glyco-Gold Nanoparticles: Advances in Targeted Therapy for Alzheimer’s Disease

7. Nucleic Acid-Based Therapies Delivered by Gold Nanoparticles

8. Immunotherapeutic Approaches Using Gold Nanoparticles in Alzheimer’s Disease

9. Regenerative Medicine: Gold Nanoparticles in Neural Tissue Repair

10. Clinical Translation of Gold Nanoparticle Therapies: Challenges and Opportunities

11. Ethical Considerations and Regulatory Aspects of Gold Nanoparticle Use

12. Future Perspectives and Emerging Trends in Gold Nanoparticle Research for Alzheimer’s Disease

Product details

  • Edition: 1
  • Latest edition
  • Published: December 1, 2026
  • Language: English

About the editors

AS

Arun Kumar Singh

Arun Kumar Singh holds an M.Pharm in Pharmaceutics from Galgotias University, India, and serves as an Assistant Professor in the Department of Pharmacy at Vivekanand Global University. He is actively engaged in teaching and interdisciplinary research spanning nano-formulation, artificial intelligence, machine learning, big data analytics, IoT, blockchain, cancer biology, and neuroscience.

Mr. Singh has made substantial scholarly contributions, authoring one book with IOP Publishing, five book chapters with River Publishers, and 28 review articles in reputed journals, including high-impact publications in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer.

In addition, he has authored and edited 58 books with leading publishers such as Elsevier, CRC Press, and Wiley. Known for his research acumen and leadership, Mr. Singh is committed to advancing pharmaceutical sciences through innovation and interdisciplinary collaboration, with a focus on impactful healthcare solutions.

Affiliations and expertise
Assistant Professor, Department of Pharmacy, Vivekanand Global University, Jaipur, Rajasthan, India

MN

Mahesh Narayan

Dr. Mahesh Narayan is a Full Professor in the Department of Chemistry and Biochemistry at the University of Texas at El Paso in the United States. Dr Narayan obtained his B.Sc. in Physics from Bombay University [1991], Ph.D. in Biophysics from The Ohio State University [1997], and pursued postdoctoral studies at Cornell University, USA [1997-2000] and was a Sr. Res. Assoc. at Cornell University [2002-05], USA. He has authored and co-authored several articles and book chapters in the fields of free radical biology, protein-structure function, oxidative folding, and protein misfolding, halogen bonding and in silico drug design, agricultural impact of nanomaterials, and chemical education. His work has been recognized by invitations to speak at over 15 international forums, as well as coverage in a variety of media outlets. The overall goal of his research program is to develop a better understanding of the intracellular processes and events that underlying the pathogenesis of neurodegenerative disorders. He is particularly interested in the effects of xenobiotics on amyloid proteins. This is since the majority of neurodegenerative disorders are sporadic, and environmental agents such as pesticides and certain drugs of abuse are risk factors for such neuropathies.
Affiliations and expertise
Full Professor, University of Texas at El Paso, USA

AP

Ashutosh Pareek

Dr. Ashutosh Pareek, Professor at Banasthali Vidyapith with over 15 years of experience in pharmaceutical sciences, holds gold medals for his Master's and Bachelor's degrees in Pharmacy. Dr. Pareek specializes in neuropharmacology and innovative drug delivery systems, focusing on neurodegenerative disorders, cancer, and autoimmune diseases. His research includes developing advanced drug delivery systems for immunomodulators like naringenin. Dr. Pareek leads a research team working on these critical health issues and has published over 45 research papers and authored five technical books. He holds an international formulation patent and has received numerous awards, including the Zee National Achievers Award 2023. His work is funded by national and international agencies such as ICMR, DST-SERB, DBT, the American Association of Pharmaceutical Scientists, and the International Brain Research Organization. He serves as a Review Editor for Frontiers in Pharmacology and Frontiers in Oncology and reviews for leading journals by Elsevier, Springer, and Bentham.

Affiliations and expertise
Professor, Department of Pharmacy, Banasthali Vidyapith, Banasthali, Tonk, Rajasthan, India